176 related articles for article (PubMed ID: 2115219)
1. Canine mast cell tumors.
O'Keefe DA
Vet Clin North Am Small Anim Pract; 1990 Jul; 20(4):1105-15. PubMed ID: 2115219
[TBL] [Abstract][Full Text] [Related]
2. Variation among pathologists in histologic grading of canine cutaneous mast cell tumors.
Northrup NC; Harmon BG; Gieger TL; Brown CA; Carmichael KP; Garcia A; Latimer KS; Munday JS; Rakich PM; Richey LJ; Stedman NL; Cheng AL; Howerth EW
J Vet Diagn Invest; 2005 May; 17(3):245-8. PubMed ID: 15945380
[TBL] [Abstract][Full Text] [Related]
3. Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome.
Camus MS; Priest HL; Koehler JW; Driskell EA; Rakich PM; Ilha MR; Krimer PM
Vet Pathol; 2016 Nov; 53(6):1117-1123. PubMed ID: 27034386
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome for MCTs of canine pinnae treated with surgical excision (2004-2008).
Schwab TM; Popovitch C; DeBiasio J; Goldschmidt M
J Am Anim Hosp Assoc; 2014; 50(3):187-91. PubMed ID: 24659731
[TBL] [Abstract][Full Text] [Related]
5. Outcome of dogs with mast cell tumors in the inguinal or perineal region versus other cutaneous locations: 124 cases (1990-2001).
Sfiligoi G; Rassnick KM; Scarlett JM; Northrup NC; Gieger TL
J Am Vet Med Assoc; 2005 Apr; 226(8):1368-74. PubMed ID: 15844431
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
[TBL] [Abstract][Full Text] [Related]
7. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
8. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
[TBL] [Abstract][Full Text] [Related]
9. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of lymph node metastasis with grade 2 MCTs in dogs: 55 cases (2001-2010).
Baginski H; Davis G; Bastian RP
J Am Anim Hosp Assoc; 2014; 50(2):89-95. PubMed ID: 24446400
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors.
Webster JD; Kiupel M; Yuzbasiyan-Gurkan V
BMC Cancer; 2006 Apr; 6():85. PubMed ID: 16579858
[TBL] [Abstract][Full Text] [Related]
12. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.
Scarpa F; Sabattini S; Marconato L; Capitani O; Morini M; Bettini G
J Am Vet Med Assoc; 2012 May; 240(10):1181-7. PubMed ID: 22559107
[TBL] [Abstract][Full Text] [Related]
13. [Mast cell tumors in dogs--diagnosis and therapy of a malignant skin tumor].
Kessler M
Tierarztl Prax; 1995 Apr; 23(2):172-8. PubMed ID: 7624860
[TBL] [Abstract][Full Text] [Related]
14. Canine mast cell tumors express stem cell factor receptor.
Reguera MJ; Rabanal RM; Puigdemont A; Ferrer L
Am J Dermatopathol; 2000 Feb; 22(1):49-54. PubMed ID: 10698217
[TBL] [Abstract][Full Text] [Related]
15. Mast cell tumour destruction in dogs by hypotonic solution.
Grier RL; Di Guardo G; Myers R; Merkley DF
J Small Anim Pract; 1995 Sep; 36(9):385-8. PubMed ID: 8583766
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
[TBL] [Abstract][Full Text] [Related]
17. Mast cell tumors in the dog.
London CA; Seguin B
Vet Clin North Am Small Anim Pract; 2003 May; 33(3):473-89, v. PubMed ID: 12852232
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs.
Simpson AM; Ludwig LL; Newman SJ; Bergman PJ; Hottinger HA; Patnaik AK
J Am Vet Med Assoc; 2004 Jan; 224(2):236-40. PubMed ID: 14736068
[TBL] [Abstract][Full Text] [Related]
19. Beclin-1 is a novel predictive biomarker for canine cutaneous and subcutaneous mast cell tumors.
Knight BJ; Wood GA; Foster RA; Coomber BL
Vet Pathol; 2022 Jan; 59(1):46-56. PubMed ID: 34521293
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994-2002).
Cahalane AK; Payne S; Barber LG; Duda LE; Henry CJ; Mauldin GE; Frimberger AE; Cotter SM; Moore AS
J Am Vet Med Assoc; 2004 Aug; 225(3):401-8. PubMed ID: 15328716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
